The effect of R-(-)-deprenyl in de novo parkinsonian patients pretreated with levodopa and decarboxylase inhibitor correlated to depression and MHPG, HIAA and HVA levels in the cerebrospinal fluid.

Przuntek, H; Kuhn, W; Kraus, P

Przuntek, H; Kuhn, W; Kraus, P.

Affiliation

Przuntek H; Neurological University Hospital, St. Josef Hospital, Bochum, W. Germany.

Acta Neurol Scand Suppl ; 126: 153-6, 1989.

Article in En | MEDLINE | ID: mdl-2482649

Subject(s)

Benserazide/therapeutic use; Depression/drug therapy; Glycols/cerebrospinal fluid; Homovanillic Acid/cerebrospinal fluid; Hydrazines/therapeutic use; Hydroxyindoleacetic Acid/cerebrospinal fluid; Levodopa/therapeutic use; Methoxyhydroxyphenylglycol/cerebrospinal fluid; Motor Activity/physiology; Parkinson Disease/drug therapy; Phenethylamines/therapeutic use; Selegiline/therapeutic use; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Parkinson Disease/cerebrospinal fluid; Parkinson Disease/physiopathology; Parkinson Disease/psychology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Phenethylamines / Selegiline / Benserazide / Levodopa / Depression / Glycols / Homovanillic Acid / Hydrazines / Hydroxyindoleacetic Acid Type of study: Clinical_trials Limits: Female / Humans / Male / Middle aged Language: En Journal: Acta Neurol Scand Suppl Year: 1989 Type: Article

Search on Google

XML

PubMed Links